Need professional-grade analysis? Visit stockanalysis.com
$116.93B
26.73
4,158
N/A
Indegene Ltd (INDGN) trades on NSE in INR. The company is classified in the Healthcare sector under the Health Information Services industry. The stock currently trades at INR487.25, down 0.03% from the previous close.
Over the past year, INDGN has traded between a low of INR429.25 and a high of INR589.55. The stock has lost 15.4% over this period. It is currently 17.4% below its 52-week high.
Indegene Ltd has a market capitalization of $116.93B, with a price-to-earnings ratio of 26.73.
Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platforms. Further, it provides analytics, technology, commercial, medical, regulatory, and safety services to life science and healthcare organizations. Indegene Limited was incorporated in 1998 and is based in Bengaluru, India.
Side-by-side comparison against top Healthcare peers.